India will comply with EU API standards; Xcelience opens new facility in FL;

> The Indian government is planning to comply with the EU's regulations on API exporters, saying it will appoint a "competent authority" to ensure that standards are met. News

> ShangPharma has entered a licensing agreement with the Dutch company Harbour Antibodies, allowing the Chinese company to develop therapeutic antibody candidates for its customers using Harbour's transgenic mouse-based antibody development technology. More

> PPD has entered an alliance with the Global Allergy and Asthma European Network, giving the CRO access to the organization's allergy and asthma experts and more than 100 research sites in Europe. Article

> Xcelience has opened a 24,000-square-foot facility in Tampa, FL, to boost its primary and secondary packaging, labeling, distribution and warehouse services. Story

> The CMO market is poised to grow 6% each year, and an increase in demand for API production will drive that expansion, according to a new report from Visiongain. Report

> Celerion achieved accreditation from the Association for the Accreditation of Human Research Protection Programs for its facilities, making it the first U.S. CRO to do so. Release

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.